Aurinia Pharmaceuticals Inc.
General ticker "AUPH" information:
- Sector: Health Care
- Industry: Biotechnology
- Capitalization: $1.3B (TTM average)
Aurinia Pharmaceuticals Inc. follows the US Stock Market performance with the rate: 52.2%.
Estimated limits based on current volatility of 2.8%: low 15.07$, high 15.95$
Factors to consider:
- Total employees count: 130 as of 2024
- US accounted for 89.4% of revenue in the fiscal year ended 2024-12-31
- Top business risk factors: Strategic risks and growth management, Regulatory and compliance, Market volatility, Single product reliance, Cybersecurity threats
- Earnings for 9 months up through Q3 exceed our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2024-12-31 to 2026-12-31
- 2024-12-31 to 2025-12-31 estimated range: [8.88$, 18.14$]
- 2025-12-31 to 2026-12-31 estimated range: [8.67$, 17.51$]
Financial Metrics affecting the AUPH estimates:
- Positive: with PPE of 50.4 at the end of fiscal year the price was very low
- Positive: -3.60 < Operating profit margin, % of -1.92
- Positive: Investing cash flow per share per price, % of 3.02 > -0.66
- Negative: negative Industry operating cash flow (median)
- Positive: Shareholder equity ratio, % of 68.55 > 63.39
- Negative: -0.15 < Industry inventory ratio change (median), % of 0
- Positive: 0.33 < Operating cash flow per share per price, % of 3.42
Short-term AUPH quotes
Long-term AUPH plot with estimates
Financial data
| YTD | 2022-12-31 | 2023-12-31 | 2024-12-31 |
|---|---|---|---|
| Operating Revenue | $135.55MM | $167.13MM | $239.48MM |
| Operating Expenses | $247.02MM | $258.82MM | $244.17MM |
| Operating Income | $-111.47MM | $-91.69MM | $-4.69MM |
| Non-Operating Income | $5.12MM | $14.22MM | $12.13MM |
| Interest Expense | $0.00MM | $2.77MM | $4.83MM |
| R&D Expense | $44.99MM | $49.64MM | $20.79MM |
| Income(Loss) | $-106.35MM | $-77.47MM | $7.45MM |
| Taxes | $1.83MM | $0.55MM | $1.70MM |
| Profit(Loss)* | $-108.18MM | $-78.02MM | $5.75MM |
| Stockholders Equity | $405.44MM | $377.95MM | $377.48MM |
| Inventory | $24.75MM | $39.70MM | $39.23MM |
| Assets | $470.86MM | $548.06MM | $550.64MM |
| Operating Cash Flow | $-79.53MM | $-33.46MM | $44.39MM |
| Capital expenditure | $0.29MM | $0.72MM | $0.28MM |
| Investing Cash Flow | $-60.63MM | $-6.71MM | $39.26MM |
| Financing Cash Flow | $2.43MM | $-5.13MM | $-49.09MM |
| Earnings Per Share** | $-0.76 | $-0.54 | $0.04 |
* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.